Indgift af eptifibatid er forbundet med en stigning i antallet af større og mindre blødninger, ifølge klassifikation efter Trombolysis in Myocardial Infarction (TIMI) study group kriterierne.
Administration of eptifibatide is associated with an increase in major and minor bleeding, as classified by the criteria of the Thrombolysis in Myocardial Infarction (TIMI) study group.